devis
novel
antiinfecti
treatment
regimen
target
specif
cellular
subtyp
crucial
know
ident
cell
respons
product
type
ifn
cours
infect
earli
pdc
consid
primari
produc
viru
infect
human
pdc
report
transcript
account
astound
mrna
cell
viral
activ
year
ago
pdc
first
describ
human
natur
ipc
activ
nk
cell
upon
exposur
virus
murin
equival
describ
type
ifn
produc
cell
plasmacytoid
morpholog
cell
detect
rna
dna
virus
two
endosom
sensor
respect
induc
secret
type
ifn
signal
pathway
specif
interact
earli
endosom
result
type
ifn
product
ligand
recognit
late
endosom
lysosom
rather
lead
inflammatori
cytokin
product
pdc
matur
least
mous
also
express
monocyt
convent
dc
cdc
b
cell
therefor
contribut
cell
type
type
ifn
product
trigger
via
pathway
consid
b
cell
instanc
recent
shown
produc
type
ifn
vivo
optim
stimul
condit
use
ligand
cpga
specif
featur
pdc
produc
type
ifn
independ
ifnar
mediat
feedback
signal
howev
respond
type
ifn
gener
autocrin
circuit
ifnar
augment
type
ifn
secret
induc
activ
migrat
human
pdc
monocyt
myeloid
cell
also
produc
type
ifn
stimul
pathway
viral
singlestrand
rna
ssrna
mous
initi
consid
nonfunct
recent
shown
mous
stimul
combin
oligodeoxynucleotid
odn
human
ligand
mous
pdc
produc
type
ifn
stimul
vaccinia
viru
vv
depend
way
two
addit
tlr
abl
induc
type
ifn
express
independ
pathway
via
recruit
tir
domaincontain
adaptor
protein
induc
interferon
beta
trif
also
known
tir
domaincontain
adapt
molecul
activ
transcript
factor
thu
initi
type
ifn
particular
express
absent
mous
pdc
highli
express
endosom
murin
human
cdc
subtyp
effici
crosspres
recogn
doublestrand
rna
dsrna
viral
replic
intermedi
well
ssrna
contain
stem
loop
addit
dc
activ
lead
type
ifn
express
macrophag
fibroblast
epitheli
cell
exclus
signal
via
trif
pathway
util
well
trif
signal
rout
recogn
cognat
ligand
bacteri
lipopolysaccharid
lp
analog
activ
lp
bind
induc
type
ifn
express
via
major
hematopoiet
cell
myeloid
lymphoid
lineag
except
human
pdc
cell
type
pancreat
express
contrast
pdc
cdc
macrophag
mainli
produc
type
ifn
respons
viru
challeng
util
retino
acidinduc
gene
rigi
like
helicas
rlh
rlh
includ
rigi
melanoma
differentiationassoci
gene
cytoplasm
dsrna
receptor
transmit
signal
mitochondri
antiviralsign
protein
virusinduc
signal
adapt
mav
aka
ifnb
promot
stimul
ip
cardif
activ
induc
transcript
type
ifn
antivir
gene
final
solubl
sensor
cytoplasm
detect
dsdna
sequenceindepend
manner
exhibit
broad
express
spectrum
includ
pdc
cdc
macrophag
mous
embryon
fibroblast
mef
activ
signal
pathway
lead
type
ifn
express
sensor
includ
cyclic
gmpamp
synthas
cga
sting
pathway
rna
polymeras
iiirigimav
pathway
dnadepend
activ
irf
dai
protein
ddx
famili
sever
model
cytokin
report
mice
develop
detect
type
ifn
product
vivo
intracellular
stain
sensit
case
tabl
figur
earlier
publish
knockout
mous
line
alreadi
contain
report
element
detect
ifnb
promoterdriven
gene
transcript
exampl
code
sequenc
mous
immunoglobulin
chain
green
fluoresc
protein
gfp
human
insert
immedi
downstream
ifnb
promot
visual
express
cellular
level
howev
report
featur
mous
strain
use
vivo
far
recent
mous
line
express
gfp
control
promot
recapitul
express
variou
gene
employ
defin
cellular
sourc
viru
infect
model
also
fluoresc
reporterknockin
mous
model
gener
yellow
fluoresc
protein
yfp
express
bicistron
mrna
link
intern
ribosom
entri
site
ire
endogen
mrna
well
report
mice
shown
report
major
type
ifn
howev
vitro
analys
bmderiv
dc
doubl
report
mous
line
gener
intercross
report
strain
reveal
specif
type
ifn
subtyp
produc
distinct
cell
subpopul
altern
report
mous
system
firefli
luciferas
report
gene
place
control
ifnb
promot
rather
express
singl
cell
level
model
detect
vivo
kinet
express
mous
parallel
spread
pathogen
organ
infecti
condit
addit
mous
line
code
sequenc
flank
loxp
site
provid
possibl
character
impact
product
given
cell
type
pathophysiolog
variou
infect
via
tissu
cellspecif
cremedi
delet
sever
experiment
strategi
develop
determin
vivo
contribut
specif
cell
type
type
ifn
respons
infect
initi
antibodi
mediat
deplet
util
frequent
ablat
pdc
monocyt
antibodi
also
known
also
known
use
deplet
pdc
vivo
vitro
howev
antibodi
gener
target
multipl
cell
type
addit
pdc
antibodi
direct
react
strongli
neutrophilspecif
antigen
crossreact
also
ag
express
pdc
well
monocytesmacrophag
activ
cell
nk
cell
plasma
cell
endotheli
cell
likewis
recogn
three
differ
antibodi
clone
also
known
express
mice
pdc
also
plasma
cell
follow
stimul
type
ifn
upregul
addit
sever
myeloid
lymphoid
cell
final
vivo
treatment
clodronatecontain
liposom
deplet
phagocyt
mice
also
disturb
microarchitectur
secondari
lymphoid
organ
past
year
sever
genet
modifi
mous
line
constitut
induc
lack
specif
cell
type
attribut
produc
type
ifn
becom
avail
tabl
figur
pdc
alreadi
sever
mous
model
exist
constitut
induc
ablat
mice
carri
hypomorph
mutat
ikaro
locu
express
low
level
transcript
factor
ikaro
ikll
therefor
lack
peripher
pdc
dc
subset
use
line
pdcless
model
one
take
account
hematopoiet
lineag
includ
b
cell
neutrophil
also
affect
ikll
mutat
ikll
mice
start
develop
thymic
lymphoma
week
age
constitut
delet
basic
helixloophelix
transcript
factor
also
known
control
develop
mainten
pdc
result
perinat
lethal
mice
overcom
lethal
specif
ablat
pdc
lineag
mice
harbor
constitut
delet
flox
allel
cross
itgaxcr
mice
cre
express
dc
induc
ubiquit
tamoxifen
administr
respect
anoth
strategi
use
diphtheria
toxin
receptor
dtr
mediat
condit
target
cell
deplet
mice
express
dtr
human
pdc
specif
promotor
ctype
lectin
domain
famili
member
also
known
blood
dendrit
cell
antigen
administr
diphtheria
toxin
dt
mice
result
transient
specif
deplet
pdc
altern
approach
cdna
encod
human
dtr
fuse
enhanc
green
fluoresc
protein
egfp
preced
ire
insert
untransl
region
siglech
gene
siglechdtrdtr
mous
model
allow
specif
elimin
pdc
vivo
via
inject
dt
analog
mous
line
term
siglechdtrtg
gener
use
bacteri
artifici
chromosom
bac
transgen
technolog
siglech
repres
sialic
iglik
lectin
exert
immunomodulatori
role
antivir
immun
respons
siglechegfpmic
heterozyg
report
gene
shown
addit
pdc
siglech
express
special
macrophag
subset
margin
zone
macrophag
mzm
lymph
node
medullari
macrophag
microglia
siglech
also
found
immedi
precursor
pdc
prepdc
bm
plastic
differenti
pdc
cdc
despit
siglech
express
describ
cell
type
loschko
et
al
show
pdc
specif
antigen
deliveri
mice
use
siglech
target
structur
suggest
usabl
siglech
lead
molecul
gener
pdc
specif
transgen
anim
side
side
comparison
show
higher
suscept
listeria
monocytogen
infect
dttreat
siglechdtrtg
vs
mice
find
attribut
addit
lack
mzm
siglechdtrtg
mice
dt
treatment
observ
mice
aim
specif
express
cre
recombinas
pdc
bactg
pdcre
mous
line
gener
express
cre
control
siglech
promot
cross
mice
report
mous
line
indic
cre
activ
via
red
fluoresc
protein
rfp
express
author
found
siglech
pdc
termin
label
rfp
addit
rfp
express
observ
minor
fraction
b
nk
nkt
cell
splenic
cdc
bm
cell
suggest
small
fraction
earli
lymphoid
progenitor
activ
transcrib
siglech
locu
thu
broader
express
pattern
siglech
consid
use
siglechdtrtg
mice
evalu
pdc
function
vivo
recent
novel
mous
model
describ
type
ifn
product
restrict
pdc
knockin
model
express
driven
siglech
promot
mice
backcross
onto
doubl
knockout
mice
defici
type
ifn
product
yield
anim
refer
pdc
mice
signal
requir
type
ifn
express
function
exclus
pdc
addit
mice
ire
site
follow
code
sequenc
cre
fuse
mutat
ligand
bind
domain
human
estrogen
receptor
insert
behind
gene
siglech
gene
locu
therefor
mous
line
potenti
use
futur
tamoxifen
induc
pdc
specif
cre
express
thu
pdc
specif
gene
delet
cross
respect
flox
mous
line
also
cell
type
pdc
dtrmediat
deplet
approach
employ
recent
year
mice
express
dtr
control
gener
success
use
deplet
monocyt
cdc
macrophag
subpopul
mzm
subcapsular
sinu
macrophag
spleen
lymph
node
follow
section
discuss
approach
design
defin
type
ifn
produc
cell
type
infect
use
vivo
mous
model
describ
infect
human
cytomegaloviru
hcmv
caus
mostli
asymptomat
latent
infect
immunocompet
host
immunosuppress
individu
newborn
infect
utero
infect
viru
lead
sever
ill
perman
organ
damag
murin
cytomegaloviru
mcmv
exhibit
high
structur
biolog
similar
hcmv
thu
wide
use
model
system
antivir
immun
respons
mcmv
induc
biphas
type
ifn
respons
peak
express
occur
h
h
pi
trigger
initi
viru
contact
viral
particl
enter
system
complet
first
viral
replic
cycl
respect
earli
type
ifn
express
independ
tlr
signal
predominantli
gener
stromal
cell
infect
viru
use
report
mice
product
detect
splenic
pdc
earli
h
pi
vivo
deplet
pdc
treatment
serum
level
sever
reduc
h
mcmv
infect
condit
howev
cell
type
secret
ensur
suffici
nk
cell
respons
lead
control
mcmv
infect
note
h
mcmv
infect
serum
level
pdc
deplet
mice
longer
reduc
compar
untreat
mice
similar
observ
made
ikll
mice
lack
pdc
mice
transient
deplet
pdc
thu
transient
type
ifn
product
first
day
mcmv
infect
pdcdepend
cell
pdc
respons
type
ifn
level
measur
later
timepoint
least
rel
high
inocula
mcmv
use
contrast
lower
dose
mcmv
presum
closer
natur
infect
set
pdc
limit
viral
burden
spleen
liver
pdc
shown
promot
nk
cell
activ
cytotox
earli
phase
mcmv
infect
wellestablish
pdc
sens
mcmv
via
mediat
pathway
also
pathway
function
use
cell
pdc
shown
involv
induct
type
ifn
product
find
accord
multipl
observ
defect
signal
sever
impact
antimcmv
immun
respons
defici
pdc
deplet
far
ident
nonpdc
cell
type
involv
antimcmv
type
ifn
respons
remain
incomplet
defin
one
report
indic
vaccinia
viru
vv
lesser
extend
mcmv
induc
type
ifn
inflammatori
monocyt
macrophag
type
dc
depend
way
use
report
mice
mice
deplet
monocyt
exhibit
increas
viral
titer
liver
decreas
serum
level
type
ifn
vv
infect
similar
studi
use
footpad
infect
modifi
vaccinia
viru
ankara
mva
pdc
deplet
mous
model
type
ifn
level
drain
lymph
node
compar
control
mice
indic
pdc
requir
mount
intact
type
ifn
respons
local
infect
dsdna
viru
dsdna
adenoviru
use
vector
develop
gene
therapi
applic
also
caus
sever
diseas
immunocompromis
individu
use
mice
treatment
ablat
cdc
vs
pdc
vivo
shown
wildtyp
wt
adenoviru
well
adenovir
vector
induc
rapid
product
almost
exclus
splenic
cdc
rather
pdc
herp
simplex
viru
hsv
local
subcutan
genit
well
system
iv
infect
model
analyz
subcutan
infect
pdc
shown
provid
type
ifn
necessari
licens
cdc
turn
induc
effect
cytotox
cell
respons
mice
deplet
pdc
treatment
display
increas
viral
titer
drain
lymph
node
day
pi
compar
control
similarli
genit
herp
model
mice
deplet
pdc
use
antibodi
succumb
earlier
infect
exhibit
reduc
local
level
respons
drain
lymph
node
develop
normal
contrast
find
antibodymedi
deplet
pdc
deplet
mice
neither
differ
viral
burden
surviv
vagin
infect
found
pdc
found
contribut
significantli
antivir
cell
respons
subcutan
inocul
contradict
find
explain
antibodymedi
deplet
addit
cell
type
pdc
contrast
restrict
deplet
genet
mous
model
hand
exclud
dtr
mediat
deplet
less
effect
therefor
residu
pdc
activ
retain
dt
administr
slight
differ
respect
experiment
set
might
contribut
well
eg
antibodymedi
pdc
deplet
level
measur
vagin
wash
genet
deplet
model
total
protein
amount
assess
vagin
cervic
tissu
mcmv
cell
dc
hematopoiet
nonhematopoiet
cell
essenti
type
ifn
product
local
hsv
infect
later
timepoint
rather
pdc
system
challeng
uvirradi
hsv
earli
studi
immunohistolog
stain
indic
major
type
ifn
produc
cell
spleen
repres
margin
metallophil
macrophag
lesser
extend
mzm
howev
level
markedli
reduc
pdc
deplet
siglechdtrdtr
mice
h
iv
infect
viral
titer
found
increas
spleen
compar
control
anim
point
toward
pdc
major
type
ifn
produc
situat
similar
result
obtain
pdc
deplet
mice
except
viral
replic
detect
spleen
either
dttreat
control
mice
discrep
may
reflect
differ
strain
use
differ
promot
use
drive
dtr
express
vs
siglech
slightli
diverg
express
pattern
discuss
system
infect
result
antibodi
deplet
pdc
ablat
mice
correspond
well
sinc
case
reduct
serum
level
observ
togeth
increas
viral
titer
reduc
surviv
thu
similar
vaccinia
viru
cell
type
respons
product
type
ifn
hsv
infect
may
depend
rout
pathogen
entri
pdc
control
infect
viru
spread
system
ectromelia
viru
ectv
larg
dna
orthopoxviru
caus
agent
mousepox
mous
homolog
human
smallpox
ectv
caus
system
diseas
sc
infect
footpad
vivo
shown
clodron
mediat
deplet
monocyt
vs
pdc
ex
vivo
sort
rtpcr
analys
infect
inflammatori
monocyt
major
produc
type
ifn
drain
lymph
node
summari
cellular
sourc
type
ifn
product
dna
viru
infect
depend
viru
type
dosag
timepoint
well
rout
infect
earli
infect
mcmv
pdc
primari
sourc
type
ifn
product
capabl
reduc
viru
titer
low
concentr
viru
howev
later
timepoint
infect
dc
rather
pdc
becom
key
sourc
type
ifn
product
addit
pdc
cell
type
cdc
adenoviru
infect
metallophil
macrophag
mzm
hsv
exposur
stromal
cell
mcmv
infect
inflammatori
monocyt
respons
ectv
essenti
sourc
type
ifn
system
infect
rna
virus
iv
inocul
paramyxoviru
newcastl
diseas
viru
ndv
shown
pdc
also
cdc
macrophag
monocyt
produc
pdc
mount
antivir
type
ifn
respons
viral
replicationindepend
manner
viru
recognit
activ
type
ifn
posit
feedback
loop
absenc
type
ifn
posit
feedback
viru
infect
also
replic
pdc
case
type
ifn
induct
occur
pdc
via
cytoplasm
rlh
howev
ssrna
virus
report
induc
type
ifn
express
pdc
replic
depend
manner
especi
vesicular
stomat
viru
vsv
captur
replic
viru
autophagosom
requir
transfer
contain
endosom
compart
local
infect
ndv
intranas
infect
cell
shift
pdc
alveolar
macrophag
cdc
util
rlh
system
type
ifn
induct
upon
sc
vsv
infect
drain
ln
contain
less
deplet
macrophag
clodron
liposom
howev
pdc
deplet
treatment
level
induc
vsv
reduc
half
compar
control
conclud
infect
subcapsular
sinu
macrophag
produc
yet
half
type
ifn
produc
pdc
stimul
directli
indirectli
infect
macrophag
later
shown
macrophag
spleen
repres
compart
enhanc
viral
replic
thu
conceiv
macrophag
potenti
type
ifn
respons
inde
indirectli
via
activ
pdc
vsv
inocul
iv
mice
transient
deplet
pdc
found
reduc
viral
titer
increas
earli
timepoint
point
rather
transient
role
pdc
antivir
immun
distantli
relat
arbovirus
dengu
denv
chikungunya
chikv
viru
recent
shown
pdc
suffici
control
virus
via
type
ifn
respons
system
well
local
infect
set
report
novel
pdc
mice
introduc
type
ifn
product
restrict
pdc
compar
doubl
defici
mice
complet
devoid
type
ifn
express
iv
infect
denv
pdc
mice
exhibit
lower
viral
load
doubl
defici
mice
howev
compar
wt
mice
higher
viral
tier
detect
pdc
mice
sc
infect
chikv
doubl
defici
mice
succumb
viru
pdc
mice
surviv
infect
exhibit
overt
clinic
symptom
similar
wt
mice
earli
control
viremia
pdc
mice
reduc
compar
wt
still
improv
compar
doubl
defici
mice
thu
analog
find
viru
infect
model
also
rna
virus
antivir
respons
mount
pdc
control
infect
viru
spread
system
infect
model
rna
virus
exhibit
specif
tropism
pdc
play
minor
role
brain
mice
infect
ssrna
la
cross
viru
product
assess
luciferas
report
mous
model
detect
astrocyt
microglia
lesser
extend
also
infect
neuron
confirm
earlier
find
express
cell
type
la
cross
viru
infect
visual
immunostain
rna
situ
hybrid
util
condit
report
activ
mice
shown
sever
neurotrop
virus
rabi
viru
rabv
theiler
murin
encephalomyel
viru
tmev
vsv
astrocyt
main
produc
infect
brain
anoth
exampl
type
ifn
express
nonmyeloid
cell
repres
cell
encephalomyocard
viru
emcv
strain
ssrna
picornaviru
tropism
insulinproduc
cell
pancrea
induc
diabet
myocard
certain
mous
strain
cell
model
shown
protect
dt
treat
mice
develop
diabet
exhibit
increas
viral
titer
pancrea
spleen
heart
associ
reduc
type
ifn
level
compar
nondeplet
control
pneumonia
viru
mice
pvm
infect
led
mark
infiltr
pdc
increas
express
type
ifn
wt
mice
transfer
pdc
led
significantli
diminish
viru
recoveri
anim
day
infect
pvm
indic
signal
pdc
requir
appropri
innat
respons
acut
pvm
infect
intratrach
infect
respiratori
syncyti
viru
rsv
shown
mediat
deplet
pdc
complet
abolish
express
protein
level
lung
correl
increas
viral
titer
exacerb
immunopatholog
lung
pdc
deplet
mice
thu
pdc
fulfil
substanti
protect
role
local
rsv
infect
initi
vitro
studi
show
spleen
cell
mice
deplet
pdc
inject
produc
respons
stimul
inactiv
influenza
viru
contrast
splenocyt
untreat
anim
product
vitro
could
attribut
pdc
popul
sort
mous
spleen
cell
howev
vivo
intranas
infect
subleth
dose
influenza
viru
pdcdefici
ikarosl
wt
mice
reveal
similar
cours
diseas
determin
eg
weight
loss
viral
titer
thu
pdc
abl
produc
type
ifn
stimul
influenza
dispens
success
antivir
immun
respons
albeit
type
ifn
level
vivo
assess
infect
model
influenza
viruslik
orthomyxoviru
thogoto
viru
thov
type
ifn
product
periton
caviti
mainli
attribut
myeloid
cell
independ
type
ifn
receptor
mediat
feedback
loop
coincid
tropism
viru
ip
infect
mous
hepat
viru
mhv
pdc
deplet
accompani
sever
diminish
serum
level
transient
pdc
deplet
lead
lethal
follow
lowdos
mhv
infect
use
studi
nevertheless
initi
viral
titer
spleen
found
increas
pdcdeplet
compar
control
mice
similar
observ
made
itgaxcr
mice
lack
pdc
mice
show
reduc
serum
level
elev
viral
load
liver
spleen
thu
pdc
appear
essenti
type
ifn
mediat
protect
system
infect
prototyp
acut
cytopath
coronaviru
mhv
lymphocyt
choriomening
viru
lcmv
infect
wide
use
studi
acut
well
chronic
infect
acut
infect
set
report
mice
pdc
found
major
type
ifn
produc
infect
strain
lcmv
addit
cdc
macrophag
specif
spleen
exhibit
gfpreport
activ
also
report
mice
macrophag
could
exclud
major
type
ifn
produc
deplet
phagocyt
cell
clodron
liposom
affect
type
ifn
serum
level
contrast
anoth
studi
use
armstrong
strain
lcmv
report
sever
reduc
serum
level
clodron
treatment
specif
small
popul
macrophag
spleen
lymph
node
recent
shown
releas
high
amount
type
ifn
lcmv
infect
select
deplet
cell
mice
result
reduc
type
ifn
level
day
pi
onward
persist
viral
titer
consequ
deplet
mice
exhibit
sever
immunopatholog
die
quickli
infect
line
product
serum
type
ifn
reduc
lcmv
infect
mice
treat
pdc
deplet
antibodi
compar
inject
control
antibodi
also
congenit
pdcdefici
itgaxcr
mice
viru
titer
earli
infect
compar
wt
control
confirm
pdc
dispens
control
acut
lcmv
infect
still
pdc
shown
transient
sourc
type
ifn
pdc
deplet
mice
led
reduc
serum
level
h
pi
lcmv
armstrong
clone
later
timepoint
contrast
observ
acut
lcmv
infect
chronic
infect
setup
use
lcmv
docil
viru
persist
day
blood
itgaxcr
mice
viru
clear
day
wt
mice
attribut
failur
suffici
cell
activ
absenc
pdc
indic
pdc
essenti
gener
function
adapt
immun
chronic
viral
infect
taken
togeth
pdc
major
sourc
type
ifn
requir
type
ifn
mediat
protect
system
infect
rna
viru
infect
ndv
vsv
denv
chikv
pvm
rsv
mhv
lcmv
howev
contribut
pdc
type
ifn
releas
type
ifn
mediat
protect
depend
titer
viru
time
infect
rout
infect
addit
pdc
cell
type
cdc
macrophag
monocyt
ndv
macrophag
vsv
astrocyt
microglia
neuron
la
cross
viru
astrocyt
rabv
tmev
vsv
cell
cdc
emcv
cdc
macrophag
lcmv
infect
significantli
contribut
type
ifn
product
thu
similar
infect
dna
virus
also
infect
rna
virus
pdc
function
involv
type
ifn
product
mostli
earli
infect
dispens
viru
control
later
stage
infect
chronic
infect
howev
pdc
provid
type
ifn
support
preserv
cell
function
hiv
activ
pdc
produc
high
level
like
via
activ
also
assum
type
ifn
produc
hiv
infect
predominantli
pdc
decreas
product
hivinfect
patient
correl
numer
function
defici
circul
pdc
direct
assess
contribut
pdc
type
ifn
level
hivinfect
howev
perform
although
type
ifn
known
mediat
antivir
immun
alway
caution
toward
detriment
role
type
ifn
hivaid
proinflammatori
natur
thu
mani
studi
shown
pdc
sourc
type
ifn
retrovir
viru
infect
vivo
howev
addit
cellular
sourc
type
ifn
requir
fulli
control
viral
infect
summari
pdc
known
sourc
type
ifn
retrovir
infect
howev
rel
contribut
pdc
vs
type
ifn
produc
overal
type
ifn
respons
immun
control
patholog
retroviru
infect
fulli
understood
well
establish
cell
well
secret
effector
cytokin
tnf
exert
protect
function
host
resist
intracellular
bacteri
pathogen
mycobacterium
tuberculosi
mtb
contrast
role
type
ifn
mtb
infect
appear
promot
infect
instead
control
infect
type
ifn
downregul
express
therebi
suppress
signal
ifnardefici
mice
display
increas
bacteri
clearanc
infect
mtb
although
bacteri
growth
lung
unaffect
vitro
studi
bmderiv
macrophag
dc
identifi
possibl
sourc
type
ifn
respons
mtb
also
human
peripher
blood
mononuclear
cell
pbmc
deriv
macrophag
especi
dc
shown
produc
type
ifn
vitro
infect
mtb
similar
mtb
promot
antimicrobi
activ
mycobacterium
lepra
wherea
type
ifn
contribut
pathogenesi
pbmcderiv
monocyt
express
ifnstimul
gene
includ
immunosuppress
cytokin
lepra
infect
vitro
far
cell
type
express
type
ifn
context
mycobacteri
infect
vivo
well
definit
function
impact
cell
await
clarif
type
ifn
inhibit
antibacteri
signal
pathway
promot
infect
case
mycobacteria
also
l
monocytogen
evolv
mechan
activ
type
ifn
pathway
benefit
intracellular
pathogen
mice
defici
ifnar
signal
resist
system
l
monocytogen
infect
compar
wt
control
mechanist
type
ifn
enhanc
suscept
system
listeria
infect
reduc
respons
decreas
number
proinflammatori
myeloid
cell
promot
express
proapoptot
gene
enhanc
cell
sensit
apoptosi
note
intragastr
foodborn
infect
l
monocytogen
type
ifn
receptor
mediat
signal
contribut
posit
surviv
infect
mice
impact
respect
emphas
rout
infect
contribut
significantli
differ
impact
type
ifn
infect
four
distinct
cell
type
report
sourc
type
ifn
product
system
l
monocytogen
infect
vivo
tabl
one
facspurifi
splenic
cell
popul
infect
mice
display
surfac
antigen
typic
macrophag
pdc
identifi
main
produc
type
ifn
also
apathogen
listeria
mutant
lack
listeriolysin
unabl
escap
phagolysosom
cytoplasm
infect
cell
stimul
synthesi
later
tipdc
effector
subtyp
inflammatori
monocyt
produc
tnf
ino
identifi
major
cell
vivo
system
l
monocytogen
infect
use
report
mice
tipdc
harbor
high
bacteri
load
locat
within
foci
infect
splenic
white
pulp
ideal
posit
activ
cell
well
nk
cell
via
type
ifn
bacteri
load
spleen
sever
increas
mice
defici
thu
lack
tipdc
thu
subtyp
inflammatori
monocyt
attribut
import
role
earli
contain
l
monocytogen
infect
overal
role
tipdc
infect
may
therefor
ambigu
regulatori
function
control
balanc
contain
infect
time
mediat
detriment
effect
type
ifn
host
interestingli
spleen
listeriainfect
mice
increas
level
type
ifn
observ
indic
altern
cell
type
produc
type
ifn
absenc
tipdc
trigger
addit
increas
bacteri
load
along
line
detriment
role
pdc
control
l
monocytogen
infect
demonstr
siglechdtrdtr
mice
ablat
pdc
caus
significantli
increas
surviv
decreas
bacteri
burden
day
pi
type
ifn
level
analyz
condit
earlier
timepoint
howev
mediat
deplet
pdc
lead
differ
bacteri
load
level
type
ifn
spleen
compar
control
anim
one
report
b
cell
found
abl
induc
stimul
heatkil
l
monocytogen
ex
vivo
isol
b
cell
activ
cytotox
function
nk
cell
manner
vivo
b
cell
subset
contribut
posit
resist
l
monocytogen
infect
mice
defici
bcell
unabl
gener
b
cell
display
increas
suscept
l
monocytogen
infect
adopt
transfer
b
cell
mice
normal
resist
l
monocytogen
infect
intracellular
bacteria
also
extracellularli
replic
bacteri
pathogen
type
ifn
either
detriment
essenti
host
defens
group
b
streptococci
gb
import
neonat
pathogen
type
ifn
receptor
signal
report
contribut
host
resist
pathogen
mice
ip
infect
gb
express
elev
level
mrna
spleen
vitro
gb
activ
type
ifn
express
periton
macrophag
bmderiv
cdc
lesser
extent
also
macrophag
pdc
complet
unabl
produc
type
ifn
gb
stimul
contrast
gb
type
ifn
induct
mix
bacteri
sepsi
model
colon
ascenden
stent
periton
casp
shown
detriment
effect
host
septic
periton
induc
mice
show
improv
surviv
bacteri
clearanc
compar
wt
control
splenic
macrophagelik
cell
could
identifi
major
produc
ex
vivo
rtpcr
analys
sort
cell
subtyp
detect
summari
type
ifn
product
detriment
effect
host
infect
intracellular
bacteria
mycobacteria
l
monocytogen
bmdc
pbmcderiv
dc
macrophag
respons
cell
type
type
ifn
product
mycobacteria
infect
l
monocytogen
four
cell
type
identifi
type
ifn
produc
name
macrophag
tipdc
inflammatori
monocyt
b
cell
case
extracellular
bacteria
cell
type
identifi
type
ifn
produc
includ
macrophag
bmdc
howev
except
intracellular
model
organ
l
monocytogen
knowledg
cellular
sourc
type
ifn
bacteri
infect
rather
scarc
bacteri
infect
effect
type
ifn
mous
model
infect
pathogen
fungi
report
benefici
detriment
host
depend
fungal
speci
rout
infect
addit
controversi
result
obtain
similar
infect
set
explain
possibl
impact
differ
microbiom
respect
mous
coloni
cell
type
respons
type
ifn
product
fungal
infect
vivo
howev
await
clarif
knowledg
import
opportunist
fungal
pathogen
aspergillu
fumigatu
vivo
studi
direct
undertaken
type
ifn
respons
trigger
fumigatu
analyz
initi
human
pdc
isol
pbmc
cell
stimul
vitro
fumigatu
hypha
detect
supernat
mice
mice
deplet
pdc
treatment
exhibit
increas
suscept
pulmonari
iv
infect
fumigatu
conidia
direct
impact
pdc
deplet
type
ifn
level
vivo
infect
howev
analyz
studi
therefor
hypothesi
pdc
mediat
protect
function
fungal
infect
directli
via
type
ifn
remain
test
malaria
import
parasit
diseas
predominantli
tropic
subtrop
african
region
caus
protozoan
parasit
plasmodium
p
falciparum
respons
sever
form
human
malari
parasit
transmit
sporozoitestag
infect
mosquito
transmit
sporozoit
rapidli
travel
liver
infect
hepatocyt
initi
clinic
silent
immunolog
activ
liverstag
infect
wellestablish
vivo
mous
model
includ
lethal
plasmodium
yoelii
ym
p
berghei
anka
lead
high
parasitemia
cerebr
malaria
cm
respect
inocul
plasmodiuminfect
erythrocyt
p
chabaudi
use
chronic
infect
model
variou
cellular
sourc
type
ifn
propos
plasmodium
infect
vitro
inocul
p
berghei
anka
infect
erythrocyt
vivo
isol
splenic
pdc
well
cdc
express
type
ifn
use
mediat
pdc
deplet
cdc
deplet
mice
shown
cdc
pdc
requir
induct
cm
addit
cdc
requir
ifnar
depend
signal
system
product
model
indic
substanti
lower
level
serum
mice
compar
infect
litterm
control
contrast
p
berghei
anka
model
p
chabaudi
infect
induc
splenic
cdc
rather
pdc
via
sens
pathway
howev
pdc
essenti
parasit
clearanc
p
chabaudi
infect
direct
vivo
analysi
perform
report
mice
reveal
p
chabaudi
infect
ifn
produc
cell
pdc
addit
pdc
splenic
red
pulp
macrophag
rpm
gener
signific
quantiti
respons
p
chabaudi
infect
contribut
cell
type
type
ifn
respons
system
defin
pdc
deplet
via
treatment
rpm
defici
mice
lethal
malaria
mous
model
p
yoelii
ym
infect
type
ifn
enhanc
inflammatori
blood
leukocyt
activ
lethal
outcom
report
mice
indic
type
ifn
produc
high
amount
bm
blood
pdc
lesser
extent
tissu
resid
pdc
deplet
pdc
use
pdc
specif
mice
confirm
pdc
major
cellular
sourc
type
ifn
sever
malaria
model
howev
deplet
pdc
also
result
slight
signific
increas
parasitemia
prime
pdc
plasmodium
activ
macrophag
essenti
propos
vivo
set
low
level
secret
type
ifn
produc
monocyt
macrophag
prime
pdc
system
product
type
ifn
malaria
data
avail
far
pdc
well
cdc
macrophag
subtyp
cell
type
respons
gener
type
ifn
respons
depend
plasmodium
speci
similar
lcmv
mycobacteria
listeria
infect
thought
earli
robust
product
type
ifn
first
h
essenti
induc
protect
innat
adapt
immun
plasmodium
late
product
type
ifn
impair
host
antimalaria
immun
respons
induct
neg
immun
regul
leishmania
spp
transmit
mammalian
organ
bite
infect
sand
fli
parasit
preferenti
infect
macrophag
also
found
cell
type
fibroblast
neutrophil
dc
depend
parasit
speci
strain
leishmania
caus
mild
sever
cutan
mucocutan
viscer
leishmaniasi
increas
product
type
ifn
observ
local
tissu
drain
lymph
node
l
major
infect
mice
diverg
report
role
type
ifn
product
control
parasit
burden
develop
diseas
patholog
depend
time
cours
infect
type
ifn
induct
exert
detriment
protect
effect
host
leishmaniasi
studi
address
cellular
sourc
type
ifn
leishmania
infect
perform
vitro
exampl
infect
murin
macrophag
l
major
l
amazonensi
lead
type
ifn
product
vitro
exposur
bmderiv
well
splenic
pdc
l
major
l
infantum
l
braziliensi
promastigot
induc
releas
manner
intriguingli
amount
type
ifn
produc
respons
leishmania
spp
compar
type
ifn
level
produc
respons
stimul
cpg
odn
experi
recent
vitro
exposur
parasit
l
donovani
report
trigger
product
splenic
b
cell
also
high
level
type
ifn
mrna
detect
splenic
b
cell
purifi
vivo
l
donovani
infect
mice
taken
togeth
depend
leishmania
subtyp
pdc
b
cell
sourc
type
ifn
cell
directli
expos
pathogen
vitro
inform
type
ifn
produc
vivo
remain
scarc
far
import
protozoan
parasit
model
could
increas
significantli
make
use
avail
mous
model
toxoplasma
gondii
intracellular
protozoan
parasit
infect
least
human
popul
caus
sever
toxoplasmosi
immunesuppress
patient
gondii
infect
wide
rang
warmblood
anim
abl
invad
nucleat
cell
surviv
outsid
mammalian
host
well
gut
epithelium
strateg
barrier
prevent
limit
parasit
dissemin
upon
oral
infect
gondii
initi
phase
oral
gondii
infect
elev
mrna
level
observ
small
intestin
intestin
epitheli
cell
iec
cell
lamina
propria
sourc
local
product
earli
infect
assess
realtim
pcr
perform
cell
isol
infect
mice
vitro
infect
gondii
report
induc
suppress
type
ifn
induct
depend
host
speci
cell
type
parasit
strain
analyz
one
public
show
bmderiv
murin
pdc
produc
infect
gondii
murin
pdc
recogn
gondii
profilin
via
produc
type
ifn
depend
fashion
contrast
murin
pdc
human
pdc
lack
unabl
produc
type
ifn
despit
direct
infect
gondii
activ
infect
gondii
vitro
rather
function
inactiv
human
pdc
particular
macrophag
dc
serv
reservoir
gondii
infect
facilit
earli
dissemin
toxoplasma
strain
test
unabl
induc
type
ifn
product
murin
bmderiv
macrophag
vitro
infect
gondii
mediat
suppress
type
ifn
express
report
also
monocyt
macrophag
sever
dc
subset
vitro
hand
atyp
toxoplasma
strain
cougar
rub
induc
product
murin
bmderiv
macrophag
well
human
skin
fibroblast
vitro
infect
system
physiolog
oral
infect
mous
model
ex
vivo
isol
inflammatori
monocyt
gutdrain
mesenter
lymph
node
identifi
major
produc
express
inflammatori
monocyt
requir
phagocyt
uptak
gondii
activ
invas
trigger
induct
thu
depend
host
speci
cell
type
parasit
strain
gondii
may
induc
suppress
type
ifn
product
epitheli
skin
fibroblast
pdc
macrophag
inflammatori
monocyt
known
cellular
sourc
type
ifn
gondii
infect
knowledg
cellular
sourc
type
ifn
deduc
vitro
experi
analysi
type
ifn
report
mous
model
without
ablat
differ
cell
type
miss
far
taken
togeth
major
type
ifn
produc
cell
type
contribut
immun
mani
protozoan
parasit
remain
defin
knowledg
direct
studi
elucid
cellular
sourc
type
ifn
multicellular
parasit
helminth
infect
vivo
publish
order
understand
cellular
sourc
type
ifn
relev
regard
diseas
elimin
multicellular
parasit
helminth
type
ifn
report
mous
model
cell
specif
deplet
model
remain
analyz
pathogen
type
review
parasit
number
site
infect
might
influenc
sens
pathway
cell
type
activ
produc
type
ifn
recent
year
gener
novel
anim
model
remark
advanc
understand
mode
action
ifn
cell
type
respons
product
context
infect
exist
knowledg
allow
depict
cell
type
singl
cell
type
respons
entir
type
ifn
product
cours
infect
rather
depend
type
infect
wide
varieti
cell
exhibit
capac
produc
type
ifn
decis
factor
type
cell
initi
type
ifn
product
type
amount
pathogen
site
stage
infect
addit
genet
background
mous
model
microbiom
statu
contribut
well
need
analyz
even
though
pdc
special
cell
type
type
ifn
product
get
increasingli
clear
vivo
contribut
antivir
immun
also
immun
respons
bacteri
fungal
parasit
infect
exhibit
restrict
pattern
time
induct
durat
import
pdc
sourc
type
ifn
earli
viru
infect
hold
true
later
timepoint
host
cell
take
domin
produc
type
ifn
impact
pdc
also
depend
rout
infect
pdc
provid
import
sourc
type
ifn
system
infect
requir
ifnmedi
antivir
immun
respons
local
tissu
seem
necessari
line
defens
broken
howev
except
rule
shown
local
infect
mhv
pdcderiv
type
ifn
mice
critic
viral
control
surviv
inde
limit
pdc
respons
caus
upregul
proapoptot
molecul
apoptosi
induct
pdc
type
ifndepend
manner
system
viral
infect
suggest
mechan
prevent
immunopatholog
due
sustain
pdcmediat
type
ifn
product
besid
pdc
mainli
macrophag
inflammatori
monocyt
cdc
abl
mount
signific
antiinfecti
type
ifn
respons
vivo
instead
singl
special
cell
type
rather
orchestr
type
ifn
express
multipl
cellular
sourc
ensur
protect
antiinfecti
immun
respons
mediat
type
ifn
elucid
synerg
redund
differ
type
ifn
produc
cell
topic
futur
studi
advanc
singl
cell
function
profil
system
biolog
approach
contribut
significantli
near
futur
identifi
exact
function
specif
cell
type
even
cell
subtyp
differ
stage
infect
spatiotempor
interact
type
ifn
produc
cell
pathogen
immun
cell
activ
type
ifn
could
help
better
dissect
divers
function
type
ifn
immun
respons
differ
stage
infect
importantli
due
sever
side
effect
type
ifn
treatment
dire
need
better
control
activ
therebi
increas
benefici
net
effect
strategi
modifi
affin
type
ifn
modul
time
avail
review
recent
new
approach
develop
improv
vaccin
strategi
defin
novel
therapeut
lead
infecti
diseas
urgent
call
time
antibiot
resist
project
increas
rapidli
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
